Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 29Pain, Postoperative 10Colorectal Neoplasms 10Neoplasms 8Brain Neoplasms 8Stomach Neoplasms 7Prostatic Neoplasms 6Lung Neoplasms 6Pancreatic Neoplasms 5Melanoma 5Ovarian Neoplasms 4Hemorrhage 4Head and Neck Neoplasms 4Agnosia 4Rectal Neoplasms 3Neurotoxicity Syndromes 3Nasopharyngeal Carcinoma 3Myoma 3Multiple Endocrine Neoplasia Type 1 3Meningioma 3Lymphoma, Non-Hodgkin 3Leiomyoma 3Glioblastoma 3Delirium 3Colonic Neoplasms 3Chronic Pain 3Warts 2Uterine Cervical Neoplasms 2Stomatitis 2Skin Neoplasms 2

Interventions

Sodium Chloride 1Saline Solution 1Observation 1Mental Status and Dementia Tests 1Health 1Exercise 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neurocognitive Disorders × Sodium Chloride × Clear all
NCT02810899 2016-09-29

Dexmedetomidine and Intelligence Development in Pediatric Patients Undergoing Craniotomy

Peking University First Hospital

Phase 4 Completed
60 enrolled
CNS

Brain Neoplasms, Neurocognitive Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡